A citation-based method for searching scientific literature

Catherine Uzan, Diaretou Ndiaye-Guèye, Marianne Nikpayam, Eva Oueld Es Cheikh, Geraldine Lebègue, Geoffroy Canlorbe, Henri Azais, Clementine Gonthier, Jeremie Belghiti, Patrick R Benusiglio, Brigitte Séroussi, Joseph Gligorov, Serge Uzan. Bull Cancer 2020
Times Cited: 2







List of co-cited articles
13 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
D Gareth R Evans, Elaine F Harkness, Adam R Brentnall, Elke M van Veen, Susan M Astley, Helen Byers, Sarah Sampson, Jake Southworth, Paula Stavrinos, Sacha J Howell,[...]. Breast Cancer Res Treat 2019
33
100

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
711
100

Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification.
Parichoy Pal Choudhury, Amber N Wilcox, Mark N Brook, Yan Zhang, Thomas Ahearn, Nick Orr, Penny Coulson, Minouk J Schoemaker, Michael E Jones, Mitchell H Gail,[...]. J Natl Cancer Inst 2020
47
100

The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
511
100

The BOADICEA model of genetic susceptibility to breast and ovarian cancer.
A C Antoniou, P P D Pharoah, P Smith, D F Easton. Br J Cancer 2004
303
100

Personalized early detection and prevention of breast cancer: ENVISION consensus statement.
Nora Pashayan, Antonis C Antoniou, Urska Ivanus, Laura J Esserman, Douglas F Easton, David French, Gaby Sroczynski, Per Hall, Jack Cuzick, D Gareth Evans,[...]. Nat Rev Clin Oncol 2020
79
100

Prediction of breast cancer risk based on profiling with common genetic variants.
Nasim Mavaddat, Paul D P Pharoah, Kyriaki Michailidou, Jonathan Tyrer, Mark N Brook, Manjeet K Bolla, Qin Wang, Joe Dennis, Alison M Dunning, Mitul Shah,[...]. J Natl Cancer Inst 2015
332
100

Large-scale genotyping identifies 41 new loci associated with breast cancer risk.
Kyriaki Michailidou, Per Hall, Anna Gonzalez-Neira, Maya Ghoussaini, Joe Dennis, Roger L Milne, Marjanka K Schmidt, Jenny Chang-Claude, Stig E Bojesen, Manjeet K Bolla,[...]. Nat Genet 2013
802
100

Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk.
Celine M Vachon, Christopher G Scott, Rulla M Tamimi, Deborah J Thompson, Peter A Fasching, Jennifer Stone, Melissa C Southey, Stacey Winham, Sara Lindström, Jenna Lilyquist,[...]. Breast Cancer Res 2019
18
100


The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions.
A C Antoniou, A P Cunningham, J Peto, D G Evans, F Lalloo, S A Narod, H A Risch, J E Eyfjord, J L Hopper, M C Southey,[...]. Br J Cancer 2008
325
100

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
100

Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes.
Nasim Mavaddat, Kyriaki Michailidou, Joe Dennis, Michael Lush, Laura Fachal, Andrew Lee, Jonathan P Tyrer, Ting-Huei Chen, Qin Wang, Manjeet K Bolla,[...]. Am J Hum Genet 2019
361
100

Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.
Suzanne A Eccles, Eric O Aboagye, Simak Ali, Annie S Anderson, Jo Armes, Fedor Berditchevski, Jeremy P Blaydes, Keith Brennan, Nicola J Brown, Helen E Bryant,[...]. Breast Cancer Res 2013
244
50

Machine learning algorithm validation with a limited sample size.
Andrius Vabalas, Emma Gowen, Ellen Poliakoff, Alexander J Casson. PLoS One 2019
235
50

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.
A C Antoniou, R Hardy, L Walker, D G Evans, A Shenton, R Eeles, S Shanley, G Pichert, L Izatt, S Rose,[...]. J Med Genet 2008
133
50


Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
Elke M van Veen, Adam R Brentnall, Helen Byers, Elaine F Harkness, Susan M Astley, Sarah Sampson, Anthony Howell, William G Newman, Jack Cuzick, D Gareth R Evans. JAMA Oncol 2018
68
50



Harms of Restrictive Risk-Based Mammographic Breast Cancer Screening.
Colleen H Neal, W Tania Rahman, Annette I Joe, Mitra Noroozian, Renee W Pinsky, Mark A Helvie. AJR Am J Roentgenol 2018
10
50

Personalizing Breast Cancer Screening Based on Polygenic Risk and Family History.
Jeroen J van den Broek, Clyde B Schechter, Nicolien T van Ravesteyn, A Cecile J W Janssens, Michael C Wolfson, Amy Trentham-Dietz, Jacques Simard, Douglas F Easton, Jeanne S Mandelblatt, Peter Kraft,[...]. J Natl Cancer Inst 2021
15
50

Evaluating Mammographer Acceptance of MammoRisk Software.
Jean Weigert, Nancy Cavanaugh, Talong Ju. Radiol Technol 2018
4
50

Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers.
Antonis C Antoniou, Andrew Shenton, Eamonn R Maher, Emma Watson, Emma Woodward, Fiona Lalloo, Douglas F Easton, D Gareth Evans. Breast Cancer Res 2006
45
50

Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen.
Andrew J Vickers, Daniel D Sjoberg, David Ulmert, Emily Vertosick, Monique J Roobol, Ian Thompson, Eveline A M Heijnsdijk, Harry De Koning, Coral Atoria-Swartz, Peter T Scardino,[...]. BMC Med 2014
57
50

Prevention of breast cancer in the context of a national breast screening programme.
A Howell, S Astley, J Warwick, P Stavrinos, S Sahin, S Ingham, H McBurney, B Eckersley, M Harvie, M Wilson,[...]. J Intern Med 2012
21
50

A calibration hierarchy for risk models was defined: from utopia to empirical data.
Ben Van Calster, Daan Nieboer, Yvonne Vergouwe, Bavo De Cock, Michael J Pencina, Ewout W Steyerberg. J Clin Epidemiol 2016
303
50


PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration.
Karel G M Moons, Robert F Wolff, Richard D Riley, Penny F Whiting, Marie Westwood, Gary S Collins, Johannes B Reitsma, Jos Kleijnen, Sue Mallett. Ann Intern Med 2019
357
50


Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
Karsten Juhl Jørgensen, Peter C Gøtzsche, Mette Kalager, Per-Henrik Zahl. Ann Intern Med 2017
81
50

Impact of adding breast density to breast cancer risk models: A systematic review.
Bolette Mikela Vilmun, Ilse Vejborg, Elsebeth Lynge, Martin Lillholm, Mads Nielsen, Michael Bachmann Nielsen, Jonathan Frederik Carlsen. Eur J Radiol 2020
14
50

BRCA1 and BRCA2 mutation predictions using the BOADICEA and BRCAPRO models and penetrance estimation in high-risk French-Canadian families.
Antonis C Antoniou, Francine Durocher, Paula Smith, Jacques Simard, Douglas F Easton. Breast Cancer Res 2006
60
50


Benefits and harms of mammography screening.
Magnus Løberg, Mette Lise Lousdal, Michael Bretthauer, Mette Kalager. Breast Cancer Res 2015
138
50


[Tailored Breast Screening Trial (TBST)].
Eugenio Paci, Paola Mantellini, Paolo Giorgi Rossi, Patrizia Falini, Donella Puliti. Epidemiol Prev 2013
8
50


BRCA in breast cancer: ESMO Clinical Practice Guidelines.
J Balmaña, O Díez, I T Rubio, F Cardoso. Ann Oncol 2011
127
50

Effect of screening mammography on breast-cancer mortality in Norway.
Mette Kalager, Marvin Zelen, Frøydis Langmark, Hans-Olov Adami. N Engl J Med 2010
328
50

Women's Benefits and Harms Trade-Offs in Breast Cancer Screening: Results from a Discrete-Choice Experiment.
Jonathan Sicsic, Nathalie Pelletier-Fleury, Nora Moumjid. Value Health 2018
18
50

Projecting individualized absolute invasive breast cancer risk in African American women.
Mitchell H Gail, Joseph P Costantino, David Pee, Melissa Bondy, Lisa Newman, Mano Selvan, Garnet L Anderson, Kathleen E Malone, Polly A Marchbanks, Worta McCaskill-Stevens,[...]. J Natl Cancer Inst 2007
203
50

What are the benefits and harms of risk stratified screening as part of the NHS breast screening Programme? Study protocol for a multi-site non-randomised comparison of BC-predict versus usual screening (NCT04359420).
David P French, Susan Astley, Adam R Brentnall, Jack Cuzick, Richard Dobrashian, Stephen W Duffy, Louise S Gorman, Elaine F Harkness, Fiona Harrison, Michelle Harvie,[...]. BMC Cancer 2020
21
50

Flawed assumptions used to defend screening mammography.
Archie Bleyer, Charles R Thomas, Cornelia Baines, Anthony B Miller. Cancer 2015
4
50


Breast cancer risk feedback to women in the UK NHS breast screening population.
D Gareth R Evans, Louise S Donnelly, Elaine F Harkness, Susan M Astley, Paula Stavrinos, Sarah Dawe, Donna Watterson, Lynne Fox, Jamie C Sergeant, Sarah Ingham,[...]. Br J Cancer 2016
51
50


Transparency and reproducibility in artificial intelligence.
Benjamin Haibe-Kains, George Alexandru Adam, Ahmed Hosny, Farnoosh Khodakarami, Levi Waldron, Bo Wang, Chris McIntosh, Anna Goldenberg, Anshul Kundaje, Casey S Greene,[...]. Nature 2020
70
50

Breast Cancer Screening: Benefit or Harm?
Karsten Juhl Jørgensen, Peter C Gøtzsche. JAMA 2016
7
50

Risk-tailored starting age of breast cancer screening based on women's reproductive profile: A nationwide cohort study.
Trasias Mukama, Mahdi Fallah, Yu Tian, Kristina Sundquist, Jan Sundquist, Hermann Brenner, Elham Kharazmi. Eur J Cancer 2020
8
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.